Holdings of First Trust NYSE Arca Biotechnology Index Fund
First Trust Exchange-Traded Fund · 30 declared positions · as of Mar 31, 2026
Original filing · Net assets 2.3B $ · Ten largest lines: 39.9 % of the equity sleeve
Sector breakdown
- Health care 40.3 %
- Materials 3.1 %
- Unattributed 56.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 86.5 %
- IE 4.2 %
- NL 3.3 %
- DE 3.2 %
- DK 2.8 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 26 | 2B $ | 86.53 % |
| IE | 1 | 96.1M $ | 4.24 % |
| NL | 1 | 74.7M $ | 3.29 % |
| DE | 1 | 71.8M $ | 3.16 % |
| DK | 1 | 63.2M $ | 2.78 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Moderna Inc | 2,351,289 | 119.4M $ | 5.26 % |
| United Therapeutics Corp | 166,849 | 98.9M $ | 4.36 % |
| Alkermes PLC | 2,719,064 | 96.1M $ | 4.24 % |
| Gilead Sciences Inc | 665,992 | 92.8M $ | 4.09 % |
| Axsome Therapeutics Inc | 521,878 | 88.2M $ | 3.89 % |
| Amgen Inc | 247,283 | 87M $ | 3.83 % |
| Corcept Therapeutics Inc | 2,150,626 | 86.7M $ | 3.82 % |
| Krystal Biotech Inc | 308,504 | 79.7M $ | 3.51 % |
| Biogen Inc | 429,853 | 78.8M $ | 3.47 % |
| Exelixis Inc | 1,831,270 | 78.5M $ | 3.46 % |
| Neurocrine Biosciences Inc | 593,926 | 78.2M $ | 3.45 % |
| Regeneron Pharmaceuticals, Inc. | 101,249 | 78.2M $ | 3.45 % |
| Vertex Pharmaceuticals Inc | 173,834 | 77.6M $ | 3.42 % |
| BioMarin Pharmaceutical Inc | 1,368,040 | 77.3M $ | 3.40 % |
| Argenx SE | 102,325 | 74.7M $ | 3.29 % |
| Sarepta Therapeutics Inc | 3,384,344 | 73.6M $ | 3.24 % |
| Halozyme Therapeutics Inc | 1,112,843 | 71.9M $ | 3.17 % |
| BioNTech SE | 807,711 | 71.8M $ | 3.16 % |
| Incyte Corp | 754,631 | 71M $ | 3.13 % |
| BEONE MEDICINES LTD | 238,672 | 70.9M $ | 3.12 % |
| Illumina Inc | 571,731 | 70.5M $ | 3.10 % |
| Natera Inc | 344,198 | 68.8M $ | 3.03 % |
| ACADIA Pharmaceuticals Inc | 3,011,495 | 67M $ | 2.95 % |
| Alnylam Pharmaceuticals Inc | 202,492 | 67M $ | 2.95 % |
| Bio-Techne Corp | 1,227,575 | 64.2M $ | 2.83 % |
| Genmab A/S | 2,354,019 | 63.2M $ | 2.78 % |
| Veracyte Inc | 1,918,341 | 61.8M $ | 2.72 % |
| Repligen Corp | 483,433 | 57M $ | 2.51 % |
| Bruker Corp | 1,480,923 | 53.5M $ | 2.36 % |
| NeoGenomics Inc | 6,128,278 | 45.5M $ | 2.00 % |